FOXO:NYE-FOXO Technologies Inc. (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 0.205

Change

+0.00 (+0.79)%

Market Cap

N/A

Volume

0.76M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-21 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

-1.48 (-1.99%)

USD 13.01B
DOCS Doximity Inc

-2.63 (-3.51%)

USD 11.03B
WEAV Weave Communications Inc

-2.63 (-15.57%)

USD 1.25B
MPLN MultiPlan Corporation

-0.19 (-0.64%)

USD 0.30B
AMWL American Well Corp

-0.32 (-2.65%)

USD 0.18B
OWLT Owlet Inc

+0.26 (+5.24%)

USD 0.08B
PHR Phreesia Inc

-0.24 (-0.84%)

N/A
VEEV Veeva Systems Inc Class A

-2.95 (-1.29%)

N/A
EVH Evolent Health Inc

-0.28 (-2.61%)

N/A
TDOC Teladoc Inc

-1.18 (-9.30%)

N/A

ETFs Containing FOXO

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -29.63% 9% A- 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -29.63% 9% A- 2% F
Trailing 12 Months  
Capital Gain -39.65% 30% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -39.65% 30% F 5% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -7.58% 40% F 8% B-
Dividend Return -7.58% 40% F 6% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 229.49% 30% F 4% F
Risk Adjusted Return -3.30% 50% F 18% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector